Glenmark gets certificate of compliance from European regulator for Baddi manufacturing unit

16 Dec 2019 Evaluate

Glenmark Pharmaceuticals has received certificate of compliance for Baddi manufacturing facility from European regulator, SUKL (State Institute for Drug control), Czech Republic. This certificate complies with the principles and guidelines of good manufacturing practice laid down in the directive 2003/94/EC which stipulates the requirements to fulfil GMP recommendations of WHO.

Baddi manufacturing unit of the company was inspected by the leading European regulator, SUKL, Czech Republic in the week of October 21, 2019.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×